Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

α N-catenin Activators

α N-catenin activators are a class of chemicals that target the modulation of the protein α N-catenin, also known as neuronal cadherin (CDH2), which plays a pivotal role in the establishment and maintenance of synaptic contacts in the nervous system. α N-catenin is involved in cell-cell adhesion processes, linking cadherins to the actin cytoskeleton and thereby influencing cell signaling, synaptic plasticity, and neuronal function.

The activation of α N-catenin by these chemicals may occur through direct or indirect mechanisms. Direct activators might interact with the α N-catenin protein itself, enhancing its affinity for binding partners like cadherins or actin, or facilitating its role in signal transduction pathways that govern synaptic function. This could involve stabilizing the protein structure, preventing its degradation, or promoting its proper localization within the cell, particularly at the synapse. Indirect α N-catenin activators may operate by influencing the expression levels of the protein, either by upregulating the transcription of the CDH2 gene or by stabilizing its mRNA, leading to increased synthesis of α N-catenin. They could also modulate the signaling pathways that impact the function of α N-catenin, such as those involved in the regulation of the cytoskeleton or intercellular junction formation. Furthermore, these activators might affect the phosphorylation status of α N-catenin, which can control its activity and interactions with other proteins. Research involving α N-catenin activators is particularly relevant in the field of neurobiology, where elucidating the molecular underpinnings of synaptic connectivity and plasticity is essential. Understanding how α N-catenin activators work offers insights into the mechanisms that control neuronal circuit formation and adaptation, which is fundamental to the comprehension of learning, memory, and the overall plasticity of the nervous system.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX inhibits PDE, leading to an increase in cAMP and cGMP levels. Increased cAMP activates PKA, which phosphorylates α N-catenin, enhancing the stability of the cadherin-catenin complex and cell-cell adhesion.